Trial intelligence / Profile preview

Naltrexone and Valproate for Bipolar Alcoholics

NCT00302133Phase 2Completed

Sponsor
University of Miami
Start
May 2006
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of naltrexone in alcohol dependence, sponsored by University of Miami. Primary endpoint: Mean Number of Standard Drinks Per Drinking Day During the Last 4 Weeks of the Trial at 12 weeks. Started May 2006; status: completed.

02

Drugs

naltrexone
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00302133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00302133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call